Pfizer Reveals Encouraging Data From Pivotal Bladder Cancer Trial
Pfizer Inc. (NYSE:PFE) released topline results from its Phase 3 CREST trial evaluating sasanlimab, an investigational ...
Chronic Disease Management: Innovations in Therapeutics, Devices, and Global Markets
According to the latest study from BCC Research, "Chronic Disease Management: Therapeutics, Device Technologies, and Global ...
BCC Research LLC: Chronic Disease Management: Innovations in Therapeutics, Devices, and Global Markets
Emerging Technologies Revolutionize Chronic Disease Management: Insights into Bio-Wearables, Digital Therapeutics, and AI-Driven Solutions BOSTON, Jan. 10, 2025 /PRNewswire/ -- According ...